Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
HGH (Somatropin) and IGF-1 LR3 operate at different points in the growth axis
If all treatment-eligible patients were to receive therapy, annual pharmaceutical spending would be $166.3 billion, including $158.3 billion among individuals using therapy solely for weight loss and $8.0 billion among those with at least one other indication
Figure 5 is a graph that shows the percentage of patients who, at the end of the treatment, reduced their weight but were still classified with grade 2 obesity in each group of the first clinical study
doi: 10.1038/304368a0 7 HolstJJOrskovCNielsenOVSchwartzTW
.png)
US$ 21.66
US$ 23.63
US$ 28.15
US$ 24.53
US$ 20.96
US$ 28.07
